Proactiveinvestors recommends
Stocktube video
13/10/2011

Fusion IP reports a full-year profit and revenue up 35%

View full size
Additional Information
Market: AIM
Sector: Technology Hardware & Equipment
EPIC: FIP
Latest Price: 70.50p  (0,00%)
52-week High: 77.50p
52-week Low: 21.50p
Market Cap: 51.33M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Fusion IP
www.fusionip.co.uk

Fusion IP owns the rights to 100% of the university-owned research generated at two of the UK's leading universities – The University of Sheffield and Cardiff University. These exclusive partnerships enable us to invest in some the world's most advanced and exciting science, turning world class research into business through the creation of a growing portfolio of companies, in fields as varied as drug discovery, alternative energy and engineering.

Full Fusion IP profile here
Pdf

Fusion IP secures £0.8 million licensing deal for University of Sheffield orthopaedic planning software

20th Nov 2009, 8:37 am Fusion IP secures £0.8 million licensing deal for University of Sheffield orthopaedic planning software

University commercialisation company Fusion IP (AIM: FIP) has licensed orthopaedic planning software developed by the medical physics team at the University of Sheffield to a global orthopaedic company in a £0.8 million deal.


According to the agreement signed with the University last year, Fusion IP has the right to license out any of its IP (intellectual property), receiving half the net income, thus receiving £0.4 million in a one-off license fee income from the deal.


Fusion expressed hopes the deal was “first of many” in Sheffield, reiterating its target of fully covering its ongoing overheads with from license income by 2011/12.


“This demonstrates that this is an achievable target....this licence deal demonstrates the value of our pipeline and endorses our ability to extrapolate real value from university research,” said Chief Executive of Fusion IP David Baynes.


Fusion IP has exclusive network agreements with the University of Sheffield and the Cardiff University, owning the rights to 100% to the university-owned research generated at these schools. Under the agreements, the universities continue to identify IP with commercial potential and patent appropriate IP disclosures, such that Fusion can select the IP with the greatest commercial potential.


The company raised £3.2 million earlier this month through a proposed subscription by its cornerstone investor IP Group (LSE: IPO) to fund the spin out of its portfolio companies.


Fusion IP currently has a portfolio of 20 active spin-out investments, expecting to spin out up to three new businesses in the period to July 2010 with further spin outs expected in 2011 and 2012.


Shares in the company rose 1.5% to 33.50 pence on the news.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.